KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Change in Inventory (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Change in Inventory for 13 consecutive years, with $87000.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 128.16% to $87000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $103000.0 through Dec 2025, up 113.86% year-over-year, with the annual reading at $103000.0 for FY2025, 113.86% up from the prior year.
  • Change in Inventory hit $87000.0 in Q4 2025 for ClearPoint Neuro, down from $498000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.5 million in Q3 2022 to a low of -$983000.0 in Q4 2023.
  • Historically, Change in Inventory has averaged $212450.0 across 5 years, with a median of $219000.0 in 2021.
  • Biggest five-year swings in Change in Inventory: soared 3680.0% in 2021 and later tumbled 346.15% in 2024.
  • Year by year, Change in Inventory stood at $1.0 million in 2021, then increased by 6.88% to $1.1 million in 2022, then plummeted by 189.12% to -$983000.0 in 2023, then soared by 68.57% to -$309000.0 in 2024, then skyrocketed by 128.16% to $87000.0 in 2025.
  • Business Quant data shows Change in Inventory for CLPT at $87000.0 in Q4 2025, $498000.0 in Q3 2025, and -$404000.0 in Q2 2025.